Bay Area's Natera Guns for a $175 Million IPO

This article was originally published here

Natera Inc, which sells non-invasive prenatal disease screening tests, on Wednesday said it has priced its initial public offering of 10 million common shares at $18.00 each, which is at the top end of its estimated range of $17 to $18 apiece.

In addition, Natera has granted the underwriters a 30-day option to purchase up to an additional 1.5 million to cover over-allotments, if any.

The shares are expected to begin trading on the Nasdaq Global Select Market on July 2 under the symbol “NTRA.” The offering is expected to close on July 8.

The company had previously filed to offer 6 million shares at a range of $15 to $17 each.

Natera, which was founded in 2003, recorded sales of $179 million for the 12 months ended March 2015.

by RTT Staff Writer

For comments and feedback: [email protected]

Business News

Glass Ceiling Top Ten Female CEOs burns marissa mayer rometty mary barra GM xerox pepsi indra

Top Ten Female CEOs Crack The Glass Ceiling

Housing Data, Fed Speeches in the Spotlight -Economic Preview for Week of March 20

Europe Ten Tallest Buildings moscow paris london frankfurt

Europe’s Ten Tallest Buildings

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply